Boothbay Fund Management’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
Boothbay Fund Management's ANRO Position: Q3 2026 in Review
Boothbay Fund Management increased its Alto Neuroscience (ANRO) stake by 20% in Q3 2026, buying an estimated $642K and bringing the position to 127,624 shares worth $3.26M. The position accounts for 0.05% of the portfolio, ranked #382.
Boothbay Fund Management first reported a position in ANRO in Q4 2024 and has held it in 8 quarters since. 131 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- Boothbay Fund Management held 127,624 shares of Alto Neuroscience worth $3.26M as of Q3 2026.
- Boothbay Fund Management bought 21,390 Alto Neuroscience shares in Q3 2026, an estimated $642K.
- Alto Neuroscience made up 0.05% of Boothbay Fund Management's portfolio in Q3 2026, its #382 holding.
- Boothbay Fund Management first reported a position in Alto Neuroscience in Q4 2024 and has held it in 8 quarters since.
- 131 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.